EGM
LGND icon

Engineers Gate Manager’s Ligand Pharmaceuticals LGND Stock Holding History

Engineers Gate Manager’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,102
Closed -$224K – 1957
2023
Q2 		$224K Sell
3,102
-1,694
-35% -$127K 0.01% 1432
2023
Q1 		$353K Sell
4,796
-9,555
-67% -$679K 0.01% 1159
2022
Q4 		$959K Buy
14,351
+10,284
+253% +$669K 0.06% 500
2022
Q3 		$218K Buy
+4,067
New +$239K 0.01% 1283
2021
Q1 		– Sell
-32,996
Closed -$2.05M – 1984
2020
Q4 		$2.05M Sell
32,996
-4,266
-11% -$243K 0.09% 329
2020
Q3 		$2.22M Buy
37,262
+31,156
+510% +$2.13M 0.1% 264
2020
Q2 		$426K Sell
6,106
-3,078
-34% -$195K 0.02% 1037
2020
Q1 		$417K Buy
9,184
+1,483
+19% +$84.1K 0.03% 883
2019
Q4 		$501K Buy
+7,701
New +$515K 0.02% 991
2019
Q2 		– Sell
-9,618
Closed -$754K – 1272
2019
Q1 		$754K Sell
9,618
-32,727
-77% -$2.48M 0.05% 518
2018
Q4 		$3.58M Buy
42,345
+252
+0.6% +$26.9K 0.29% 96
2018
Q3 		$7.21M Buy
+42,093
New +$6.35M 0.55% 22

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Engineers Gate Manager's LGND Position: Q3 2023 in Review

Engineers Gate Manager sold out of Ligand Pharmaceuticals (LGND) in Q3 2023, closing a stake of 3,102 shares — an estimated $224K sold.

Engineers Gate Manager first reported a position in LGND in Q3 2018 and held it in 12 quarters. The position peaked at $7.21M in Q3 2018. 196 funds tracked by Wall St. Rank hold LGND as of Q3 2023.

  • Engineers Gate Manager reported no remaining Ligand Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 3,102 Ligand Pharmaceuticals shares in Q3 2023, an estimated $224K.
  • Engineers Gate Manager first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 12 quarters.
  • Engineers Gate Manager's Ligand Pharmaceuticals position peaked at $7.21M in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2023.

Based on Engineers Gate Manager's 13F filing for Q3 2023, filed 14 Nov 2023.